A Cohort Study in Liver Transplant Patients Converted From a Tacrolimus Twice a Day (Prograf) to Tacrolimus Once a Day (Advagraf). French, Multisite, Observational Study

Trial Profile

A Cohort Study in Liver Transplant Patients Converted From a Tacrolimus Twice a Day (Prograf) to Tacrolimus Once a Day (Advagraf). French, Multisite, Observational Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms COBALT
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 31 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 18 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
    • 18 Jun 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top